Advances in the treatment of multiple myeloma.
Barlogie
B
B
Division of Hematology/Oncology, Arkansas Cancer Research Center, Little Rock, USA.
Jagannath
S
S
Tricot
G
G
Desikan
K R
KR
Fassas
A
A
Siegel
D
D
D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001695:Biology; D016026:Bone Marrow Transplantation; D016022:Case-Control Studies; D017322:Clinical Trials, Phase II as Topic; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007674:Kidney Diseases / Q000503:physiopathology; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology / Q000532:radiotherapy / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D016879:Salvage Therapy; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous